重新审视三尖瓣反流:历史的见解和新兴的研究观点。

IF 3.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Claudia Gonzalez-Cucharero, Gemma Vilahur, Marta Saura, Rocío Hinojar, Jose L Zamorano, Carlos Zaragoza
{"title":"重新审视三尖瓣反流:历史的见解和新兴的研究观点。","authors":"Claudia Gonzalez-Cucharero, Gemma Vilahur, Marta Saura, Rocío Hinojar, Jose L Zamorano, Carlos Zaragoza","doi":"10.1111/eci.70138","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Tricuspid regurgitation (TR), defined as the failure of proper leaflet coaptation during systole, is a common but often underrecognized valvular disorder. TR continues to rise, primarily due to population aging and the broader application of advanced diagnostic imaging techniques. Recent studies have established a clear association between TR and increased morbidity and mortality, thereby challenging its historical perception as a benign condition.</p><p><strong>Methods: </strong>The development of novel interventional therapies, combined with enhanced insight into the pathophysiology of right-sided heart failure, has prompted a shift towards earlier diagnosis and more proactive clinical management.</p><p><strong>Aim: </strong>Several gaps between novel scientific advancements and clinical translation still make this disease deserving of further attention.</p><p><strong>Discussion and conclusion: </strong>In this review, we examine the most recent advances in understanding TR, which have enabled improved segmentation of affected patient populations. This progress has made it possible to identify key prognostic markers-particularly those related to disease progression-allowing for more accurate risk stratification and significantly more personalized treatment approaches.</p>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":" ","pages":"e70138"},"PeriodicalIF":3.6000,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Revisiting tricuspid regurgitation: Historical insights and emerging research perspectives.\",\"authors\":\"Claudia Gonzalez-Cucharero, Gemma Vilahur, Marta Saura, Rocío Hinojar, Jose L Zamorano, Carlos Zaragoza\",\"doi\":\"10.1111/eci.70138\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Tricuspid regurgitation (TR), defined as the failure of proper leaflet coaptation during systole, is a common but often underrecognized valvular disorder. TR continues to rise, primarily due to population aging and the broader application of advanced diagnostic imaging techniques. Recent studies have established a clear association between TR and increased morbidity and mortality, thereby challenging its historical perception as a benign condition.</p><p><strong>Methods: </strong>The development of novel interventional therapies, combined with enhanced insight into the pathophysiology of right-sided heart failure, has prompted a shift towards earlier diagnosis and more proactive clinical management.</p><p><strong>Aim: </strong>Several gaps between novel scientific advancements and clinical translation still make this disease deserving of further attention.</p><p><strong>Discussion and conclusion: </strong>In this review, we examine the most recent advances in understanding TR, which have enabled improved segmentation of affected patient populations. This progress has made it possible to identify key prognostic markers-particularly those related to disease progression-allowing for more accurate risk stratification and significantly more personalized treatment approaches.</p>\",\"PeriodicalId\":12013,\"journal\":{\"name\":\"European Journal of Clinical Investigation\",\"volume\":\" \",\"pages\":\"e70138\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-10-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Clinical Investigation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/eci.70138\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/eci.70138","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:三尖瓣反流(TR)是一种常见但常被忽视的瓣膜疾病,被定义为收缩期小叶适应失败。TR继续上升,主要是由于人口老龄化和先进诊断成像技术的广泛应用。最近的研究已经确定了TR与发病率和死亡率增加之间的明确关联,从而挑战了其作为良性疾病的历史观念。方法:新型介入治疗的发展,结合对右侧心力衰竭病理生理学的深入了解,促使了向早期诊断和更积极的临床管理的转变。目的:新的科学进展与临床转化之间的一些差距仍然使该疾病值得进一步关注。讨论和结论:在这篇综述中,我们研究了理解TR的最新进展,这些进展使受影响患者群体的分割得到了改善。这一进展使得确定关键的预后标志物成为可能,特别是那些与疾病进展相关的标志物,从而允许更准确的风险分层和更个性化的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Revisiting tricuspid regurgitation: Historical insights and emerging research perspectives.

Background: Tricuspid regurgitation (TR), defined as the failure of proper leaflet coaptation during systole, is a common but often underrecognized valvular disorder. TR continues to rise, primarily due to population aging and the broader application of advanced diagnostic imaging techniques. Recent studies have established a clear association between TR and increased morbidity and mortality, thereby challenging its historical perception as a benign condition.

Methods: The development of novel interventional therapies, combined with enhanced insight into the pathophysiology of right-sided heart failure, has prompted a shift towards earlier diagnosis and more proactive clinical management.

Aim: Several gaps between novel scientific advancements and clinical translation still make this disease deserving of further attention.

Discussion and conclusion: In this review, we examine the most recent advances in understanding TR, which have enabled improved segmentation of affected patient populations. This progress has made it possible to identify key prognostic markers-particularly those related to disease progression-allowing for more accurate risk stratification and significantly more personalized treatment approaches.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.50
自引率
3.60%
发文量
192
审稿时长
1 months
期刊介绍: EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信